RecruitingNot ApplicableNCT06787885
Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema
Sponsor
Fayoum University
Enrollment
90 participants
Start Date
May 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the impact of using different antibiotic regimens including single and combined agents as the empirical therapy and evaluate the clinical outcomes regarding safety, efficacy, and pharmacodynamics parameters.
Eligibility
Inclusion Criteria1
- Confirmed Diagnosis of Empyema: Patients with a clinical and radiological diagnosis of
Exclusion Criteria2
- - Hypersensitivity or Allergy to the selected antibiotic: Patients with a known history of hypersensitivity or allergic reactions to used antibiotics.
- - Pregnancy and Lactation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGLevofloxacin + clindamycin
Group 1
DRUGLevofloxacin + cefipime
Group 2
DRUGMoxifloxacin + meronam
Group 3
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06787885